Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia
Abstract Background Frequency relapses are common in Philadelphia chromosome-positive (Ph-positive) acute lymphoblastic leukemia (ALL) following tyrosine kinase inhibitors (TKIs). CDKN2A/B is believed to contribute to this chemotherapy resistance. Methods To further investigate the association betwe...
Main Authors: | Na Xu, Yu-ling Li, Xuan Li, Xuan Zhou, Rui Cao, Huan Li, Lin Li, Zi-yuan Lu, Ji-xian Huang, Zhi-ping Fan, Fen Huang, Hong-sheng Zhou, Song Zhang, Zhi Liu, Hong-qian Zhu, Qi-fa Liu, Xiao-li Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-04-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-016-0270-5 |
Similar Items
-
Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood
by: Hong Hoe Koo
Published: (2011-03-01) -
Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
by: Claudio Cerchione, et al.
Published: (2021-03-01) -
Philadelphia chromosome-positive lymphoblastic lymphoma—Is it rare or underdiagnosed?
by: Ahmad Alshomar, et al.
Published: (2020-12-01) -
Patients in Focus: What's Relevant for Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia?
by: Michele Baccarani, et al.
Published: (2017-08-01) -
CDKN2A/p16INK4a DELETION IS NOT A POOR PROGNOSTIC FACTOR IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED ACCORDING TO PROTOCOL RALL-2009
by: I. S. Piskunova, et al.
Published: (2017-10-01)